Human apolipoprotein A-II protects against diet-induced atherosclerosis in transgenic rabbits.
Human apolipoprotein A-II protects against diet-induced atherosclerosis in transgenic rabbits.
复制标题
DOI:
10.1161/atvbaha.112.300445
复制
发表时间:
2013-02
期刊:
影响因子:
--
通讯作者:
Fan J
中科院分区:
文献类型:
--
作者:
Wang Y;Niimi M;Nishijima K;Waqar AB;Yu Y;Koike T;Kitajima S;Liu E;Inoue T;Kohashi M;Keyamura Y;Yoshikawa T;Zhang J;Ma L;Zha X;Watanabe T;Asada Y;Chen YE;Fan J
Apolipoprotein A-II (apo A-II) is the second major apolipoprotein of HDLs, yet its pathophysiological roles in the development of atherosclerosis remain unknown. We aimed to examine whether apo A-II plays any role in atherogenesis and if so, to elucidate the mechanism involved. We compared the susceptibility of human apo A-II transgenic (Tg) rabbits to cholesterol diet-induced atherosclerosis with non-Tg littermate rabbits. Tg rabbits developed significantly less aortic and coronary atherosclerosis than their non-Tg littermates while total plasma cholesterol levels were similar. Atherosclerotic lesions of Tg rabbits were characterized by reduced macrophages and smooth muscle cells and apo A-II immunoreactive proteins were frequently detected in the lesions. Tg rabbits exhibited low levels of plasma CRP and blood leukocytes compared to non-Tg rabbits and HDLs of Tg rabbit plasma exerted stronger cholesterol efflux activity and inhibitory effects on the inflammatory cytokine expression by macrophages in vitro than HDLs isolated from non-Tg rabbits. In addition, β-VLDLs of Tg rabbits were less sensitive to copper-induced oxidation than β-VLDLs of non-Tg rabbits. These results suggest that enrichment of apo A-II in HDL particles has atheroprotective effects and apo A-II may become a target for the treatment of atherosclerosis.